Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

Glutaminyl cyclase - Proteopedia, life in 3D

PDF) The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease

Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents - ScienceDirect

Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer's Disease

Therapeutic potential of glutaminyl cyclases: Current status and emerging trends - ScienceDirect

Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design - ScienceDirect

Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases - ScienceDirect

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

RCSB PDB - 3SI1: Structure of glycosylated murine glutaminyl cyclase

Some benzimidazole-based Glutaminyl Cyclase Inhibitors.

Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology